RXST - RxSight, Inc.
About RxSight, Inc. (https://www.rxsight.com)
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Eric J. Weinberg | Chief Business Development Officer | 1961 | $2,746,290 USD |
| Mark Wilterding | Chief Financial Officer | 1978 | $877,380 USD |
| Ronald Kurtz | President, Chief Executive Officer & Director | 1963 | $834,131 USD |
| Ilya Goldshleger | Chief Operating Officer | 1975 | $634,007 USD |
| Scott Gaines | Chief Customer Officer | 1969 | $472,053 USD |
| Adam Dashe | Executive Vice President of International | – | – |
| Jim Schindler | Executive VP & General Counsel | – | – |
| Maureen O'Connell | Executive Vice President of Clinical & Regulatory Affairs | – | – |
| Oliver Moravcevic | Vice President of Investor Relations | – | – |
| Patrick Cullen | Executive Vice President of Quality & Infrastructure Operations | – | – |